| Literature DB >> 21427404 |
Andrew Prendergast1, A Sarah Walker, Veronica Mulenga, Chifumbe Chintu, Diana M Gibb.
Abstract
The impact of cotrimoxazole (CTX) on growth and/or anemia was investigated in 541 human immunodeficiency virus-infected, antiretroviral therapy-naive Zambian children enrolled in the Children with HIV Antibiotic Prophylaxis trial. Compared with children randomized to receive placebo, children randomized to receive CTX had slower decreases in weight-for-age (P=.04) and height-for-age (P=.01), and greater increase in hemoglobin level (P=.01). These findings argue for expanded early CTX use.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21427404 DOI: 10.1093/cid/cir029
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079